| |
Nano Group |
Ferro Group |
Stenting Control |
ANOVA, p value |
| No. enrolled patients |
60 |
60 |
60 |
NA |
| Mean duration of the follow-up, months |
54 ± 13
(95% CI: median 57, min 47, max 60) |
49 ± 14
(95% CI: median 52, min 41, max 60) |
56 ± 17
(95% CI: median 57, min 45, max 60) |
NS |
| Subset |
Stent proximal |
Pre-dilatation with balloon |
No preparation |
Stent proximal |
Pre-dilatation with balloon |
No preparation |
|
NA |
| No. patients (%) |
n=6
(10.0%) |
n=9
(15.0%) |
n=45
(75.0%) |
n=7
(11.7%) |
n=11
(18.3%) |
n=42
(70.0%) |
n=60
(100%) |
NA |
| Patients lost to follow-up, no. (%) |
1 (16.7%) |
1 (11.1%) |
11 (24.4%) |
0 (0%) |
1 (9.1%) |
8 (17.8%) |
9 (15.0%) |
NA |
| Event-free survival (all cause), no. (%) |
6 (100%) |
9 (100%) |
24 (53.3%) |
6 (85.7%) |
10 (90.9%) |
14 (33.3%) |
34 (56.7%) |
NS*, <0.05# |
| Target lesion cardiac death, no. (%) |
0 (0%) |
0 (0%) |
2 (4.4%) |
0 (0%) |
1 (9.1%) |
2 (4.8%) |
3 (5.0%) |
NS |
| Target vessel cardiac death, no (%) |
1 (16.7%) |
1 (11.1%) |
2 (4.4%) |
1 (14.3%) |
2 (18.2%) |
3 (7.1%) |
7 (11.7%) |
NS*, <0.05# |
| Non-cardiac death, no. (%):
•Stroke
•Trauma
•Cancer
•Others
|
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%) |
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%) |
15 (33.3%)
3 (6.7%)
4 (8.9%)
6 (13.3%)
2 (4.4%) |
1 (14.3%)
1 (14.3%)
0 (0%)
0 (0%)
0 (0%) |
1 (9.1%)
0 (0%)
1 (9.1%)
0 (0%)
0 (0%) |
17 (40.5%)
3 (7.1%)
4 (9.5%)
8 (19.0%)
2 (4.8%) |
16 (26.7%)
6 (10.0%)
5 (8.3%)
4 (6.7%)
1 (1.7%) |
NS*, <0.05# for each variable |
| Target lesion myocardial infarction, no. (%) |
0 (%) |
0 (%) |
2 (4.4%) |
0 (0%) |
1 (9.1%) |
2 (4.8%) |
4 (6.7%) |
NS |
| Target vessel myocardial infarction, no. (%) |
1 (16.7%) |
1 (11.1%) |
5 (11.1%) |
1 (14.3%) |
2 (18.2%) |
7 (16.7%) |
10 (16.7%) |
NS |
| Target lesion revascularization (TLR), no. (%) |
0 (0%) |
0 (0%) |
4 (8.9%) |
0 (0%) |
1 (9.1%) |
4 (9.5%) |
6 (10.0%) |
NS |
| Target vessel revascularization (TVR), no. (%) |
1 (16.7%) |
1 (11.1%) |
8 (17.8%) |
1 (14.3%) |
2 (18.2%) |
13 (30.9%) |
14 (23.3%) |
NS |
Thrombosis of culprit artery, no. (%)
•ARC definite thrombosis
|
0 (0%)
0 (0%) |
0 (0%)
0 (0%) |
2 (4.4%)
2 (4.4%) |
0 (0%)
0 (0%) |
1 (9.1%)
1 (9.1%) |
3 (7.1%)
3 (7.1%) |
6 (10.0%)
6 (10.0%) |
NS |
Newcomers with diabetes mellitus, no. (%)
•Insulin-dependent
|
2 (33.3%)
2 (33.3%) |
2 (22.2%)
0 (10.0%) |
4 (8.9%)
4 (8.9%) |
6 (85.7%)
1 (14.3%) |
3 (27.3%)
1 (9.1%) |
10 (23.8%)
3 (7.1%) |
12 (20.0%)
5 (8.3%) |
NS*,
<0.05# |
| Newcomers with SYNTAX score ≥23, no. (%) |
1 (16.7%) |
1 (11.1%) |
4 (8.9%) |
0 (0%) |
2 (18.2%) |
9 (21.4%) |
9 (15.0%) |
<0.05 FAC |
NS - non-significant (p value>0.05). NA – non-available, or not applicable. FAC – for all comparisons
